Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

Src

Src (proto-oncogene tyrosine-protein kinase) is a non-receptor protein tyrosine kinase family including 9 members and promotes survival, angiogenesis, proliferation and invasion pathways.

Items 1-10 of 24

Page
per page
  1. Dasatinib (BMS-354825)
    A3017 Dasatinib (BMS-354825)
     4 Citation
    Summary: Src and BCR-Abl inhibitor
      ≥24.4 mg/mL
  2. Dasatinib hydrochloride
    A3351 Dasatinib hydrochloride
    Summary: Multi-BCR/Abl and Src kinase inhibitor, oral active
      insoluble in EtOH; insoluble in H2O; ≥8.41 mg/mL
  3. KX2-391 dihydrochloride
    A3535 KX2-391 dihydrochloride
    Target: Src
    Summary: Src kinase inhibitor
      ≥25.2 mg/mL
  4. XL228
    A3939 XL228
    Summary: IGF1R/AURORA /FGFR1-3/ABL/SRC family kinases inhibitor
      ≥21.9 mg/mL
  5. PP 1
    A8215 PP 1
    Target: Src|EGFR|JAK|ZAP-70
    Summary: Src family tyrosine kinase inhibitor
  6. PP 2 (AG 1879)
    A8216 PP 2 (AG 1879)
     1 Citation
    Summary: Src-family kinases inhibitor
      insoluble in H2O; ≥15.1 mg/mL
  7. Bosutinib (SKI-606)
    A2149 Bosutinib (SKI-606)
     1 Citation
    Target: Bcr-Abl|Src
    Summary: Potent Abl/Src kinases
      ≥26.5 mg/mL
  8. Saracatinib (AZD0530)
    A2133 Saracatinib (AZD0530)
     3 Citation
    Target: Src
    Summary: Src/Abl inhibitor,potent and selective
      ≥27.1 mg/mL
  9. Fingolimod (FTY720)
    A8548 Fingolimod (FTY720)
    Target: S1P receptors
    Summary: S1P receptors agonist
  10. NVP-BHG712
    A8683 NVP-BHG712
    Target: Eph Receptors|VEGFR
    Summary: EphB4 inhibitor,potent and selective
      ≥25.15 mg/mL

Items 1-10 of 24

Page
per page